This inventor holds 1 USPTO granted patent. Top assignee: The University of Manchester. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Harmesh S Aojula: Innovator in Targeted Lipid Vesicle Particles
Introduction
Harmesh S Aojula is a notable inventor based in Saddleworth, GB. He has made significant contributions to the field of biomedical engineering, particularly in the development of targeted lipid vesicle particles. His innovative work focuses on enhancing the delivery of therapeutic agents to specific cell types.
Latest Patents
Aojula holds a patent for lipid vesicle particles that are capable of being targeted to a specific cell type of interest. This patent describes particles that incorporate a peptide responsive to predetermined metabolic signals from the targeted cell. The modulation of permeability of these particles allows for the activation of a species intended for targeting the cell. These particles have potential applications in methods for detecting cells, treating cells, and therapeutic interventions.
Career Highlights
Harmesh S Aojula is affiliated with The University of Manchester, where he continues to advance his research in lipid-based drug delivery systems. His work has garnered attention for its innovative approach to addressing challenges in targeted therapy.
Collaborations
Aojula has collaborated with esteemed colleagues, including David J Clarke and Michael H Harrison, to further enhance the impact of his research in the field.
Conclusion
Harmesh S Aojula's contributions to the development of targeted lipid vesicle particles represent a significant advancement in biomedical engineering. His innovative approach has the potential to transform therapeutic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile